GATD3A-deficiency-induced mitochondrial dysfunction facilitates senescence of fibroblast-like synoviocytes and osteoarthritis progression DOI Creative Commons
Kai Shen, Hao Zhou, Qiang Zuo

et al.

Nature Communications, Journal Year: 2024, Volume and Issue: 15(1)

Published: Dec. 30, 2024

Accumulating evidence indicates that cellular senescence is closely associated with osteoarthritis. However, there limited research on the mechanisms underlying fibroblast-like synoviocyte and its impact osteoarthritis progression. Here, we elucidate a positive correlation between progression reveal GATD3A deficiency induces senescence. Mechanistically, enhances binding of Sirt3 to MDH2, leading deacetylation decreased activity MDH2. Reduced MDH2 impairs tricarboxylic acid cycle flux, resulting in mitochondrial dysfunction Intra-articular injection recombinant adeno-associated virus carrying significantly alleviates phenotype male mice. This study increases our current understanding function. In particular, novel mechanism senescence, suggesting targeting potential therapeutic approach for The are unclear. authors show mice demonstrate symptoms mouse models

Language: Английский

A ROS-responsive hydrogel encapsulated with matrix metalloproteinase-13 siRNA nanocarriers to attenuate osteoarthritis progression DOI Creative Commons
Qiuyang Wang, Kai Feng,

Guangsheng Wan

et al.

Journal of Nanobiotechnology, Journal Year: 2025, Volume and Issue: 23(1)

Published: Jan. 16, 2025

RNA interference (RNAi) and oxidative stress inhibition therapeutic strategies have been extensively utilized in the treatment of osteoarthritis (OA), most prevalent degenerative joint disease. However, synergistic effects these approaches on attenuating OA progression remain largely unexplored. In this study, matrix metalloproteinase-13 siRNA (siMMP-13) was incorporated onto polyethylenimine (PEI)-polyethylene glycol (PEG) modified Fe3O4 nanoparticles, forming a nucleic acid nanocarrier termed si-Fe NPs. Subsequently, poly(vinyl alcohol) (PVA) crosslinked phenylboronic (PBA)-modified hyaluronic (HA) hydrogel (HPP) used to encapsulate NPs, resulting bifunctional (si-Fe-HPP) with reactive oxygen species (ROS)-responsive RNAi properties. Studies vitro demonstrated that si-Fe-HPP exhibited excellent biocompatibility, anti-inflammatory prolonged stable retention time knee joint. Intra-articular injection significantly attenuated cartilage degradation mice destabilization medial meniscus (DMM)-induced OA. The not only notably alleviated synovitis, osteophyte formation subchondral bone sclerosis, but also markedly improved physical activity reduced pain DMM-induced mice. This study reveals si-Fe-HPP, its ROS-responsive abilities, can protect chondrocytes attenuate progression, providing novel insights directions for development materials treatment.

Language: Английский

Citations

4

Engineered MSC‐sEVs as a Versatile Nanoplatform for Enhanced Osteoarthritis Treatment via Targeted Elimination of Senescent Chondrocytes and Maintenance of Cartilage Matrix Metabolic Homeostasis DOI Creative Commons
Kai Feng, Jiashuo Liu,

Liangzhi Gong

et al.

Advanced Science, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 4, 2025

Abstract Chondrocyte senescence is an important pathogenic factor causing osteoarthritis (OA) progression through persistently producing pro‐inflammatory factors. Mesenchymal stem cells‐derived small extracellular vesicles (MSC‐sEVs) have shown anti‐inflammatory effects in OA models, while persistent existence of senescent chondrocytes still promotes cartilage destruction. Therefore, improving the targeted elimination ability on required to facilitate translation MSC‐sEVs treatment. In this study, versatile engineered are developed targetedly clear and maintain metabolic homeostasis. Specifically, loaded with siRNA mouse double minute 2 homologue (siMDM2) modified cartilage‐targeting peptide WYRGRL‐PEG 2K ‐DSPE (WPD), named WPD‐sEVs siMDM2 . The results demonstrate modification improves cellular uptake chondrocytes, thus antiaging effects. Importantly, multifunctional enhances penetration extends joint retention time MSC‐sEVs. both post‐traumatic mice naturally aged mice, more effectively eliminates maintained matrix By using P53 phosphorylation inhibitor, essential role MDM2‐P53 pathway function verified. ex vivo cultured human explants, it confirmed that alleviates phenotype. Altogether, findings suggest promising translational potential for

Language: Английский

Citations

1

Response eQTLs, chromatin accessibility, and 3D chromatin structure in chondrocytes provide mechanistic insight into osteoarthritis risk DOI
Nicole E. Kramer, Seyoun Byun, Philip Coryell

et al.

Cell Genomics, Journal Year: 2025, Volume and Issue: 5(1), P. 100738 - 100738

Published: Jan. 1, 2025

Language: Английский

Citations

1

The intersection of aging and estrogen in osteoarthritis DOI Creative Commons
Aysegul Atasoy‐Zeybek,

Kelly K. Showel,

Christopher V. Nagelli

et al.

npj Women s Health, Journal Year: 2025, Volume and Issue: 3(1)

Published: Feb. 25, 2025

Osteoarthritis (OA) is a chronic joint disease characterized by cartilage degradation, inflammation, and pain. While multiple factors contribute to OA development, age sex are primary risk factors, particularly affecting postmenopausal women. The dramatic increase in after menopause suggests estrogen deficiency accelerates progression. This review explores the molecular mechanisms connecting aging focusing on key genes pathways identified through RNA sequencing.

Language: Английский

Citations

1

Epidemiological trends and characteristics of osteoarthritis in China during 1990–2021 DOI Creative Commons
Sheng Chen, Mingjue Chen, Chao Chen

et al.

Journal of Orthopaedic Translation, Journal Year: 2025, Volume and Issue: 51, P. 218 - 226

Published: March 1, 2025

Language: Английский

Citations

1

The inflammatory endotype in osteoarthritis: Reflections from the 2024 OARSI Clinical Trials Symposium (CTS) with a special emphasis on feasibility for clinical development DOI Creative Commons
M.A. Karsdal, Lucio C. Rovati, J. Tambiah

et al.

Osteoarthritis and Cartilage Open, Journal Year: 2025, Volume and Issue: unknown, P. 100572 - 100572

Published: Jan. 1, 2025

Language: Английский

Citations

0

Therapeutic targets in aging-related osteoarthritis: A focus on the extracellular matrix homeostasis DOI Creative Commons
Hao Wan, Ming‐Fu Chang, Di Shi

et al.

Life Sciences, Journal Year: 2025, Volume and Issue: unknown, P. 123487 - 123487

Published: Feb. 1, 2025

Language: Английский

Citations

0

Bibliometric analysis of research trends and emerging insights of osteoarthritis and chondrocyte hypertrophy DOI Creative Commons

Jiajin Fang,

Shuai Wang

Frontiers in Surgery, Journal Year: 2025, Volume and Issue: 12

Published: April 10, 2025

This study aims to systematically analyze the intersection of OA and chondrocyte hypertrophy using bibliometric methods, providing an quantitative comprehensive overview current research status emerging trends in this field. Relevant publications were retrieved from Web Science Core Collection database search query TS = ("chondrocyte* hypertroph*" OR "hypertrophic chondrocyte*" "cartilage hypertroph*") AND ("osteoarthriti*" "OA" "degenerative arthritis"). Several tools, including Vosviewer, CiteSpace, R package (bibliometrix), Excel 2021, utilized on OA. A total 639 publications, published between 1995 2025, identified. The findings indicate a steady global increase hypertrophy, with increasing number studies being high-impact journals, suggesting promising developmental trajectory. China United States are leading OSTEOARTHRITIS CARTILAGE is identified as core journal area, while ANNALS OF THE RHEUMATIC DISEASES has highest impact factor among top publishing journals. Keyword analysis reveals that hotspots primarily focus stem cells, tissue engineering, cartilage repair, inflammation, oxidative stress, autophagy, apoptosis, senescence, related bioactive factors. elucidates at crucial references for future research. Future should continue these potential therapeutic approaches, key phenotypes, regulatory mechanisms, enhance international cooperation develop more effective strategies treatments

Language: Английский

Citations

0

Constructing machine learning-based risk prediction model for osteoarthritis in population aged 45 and above: NHANES 2011–2018 DOI Creative Commons
Yun Fu, Yaming Yu,

Weichao Chen

et al.

Scientific Reports, Journal Year: 2025, Volume and Issue: 15(1)

Published: April 24, 2025

Language: Английский

Citations

0

Targeting p38 MAPK: A potential bridge between ER stress and age-related bone loss DOI
Meng Yin, Xin Zheng, Liang Shi

et al.

Cellular Signalling, Journal Year: 2024, Volume and Issue: 127, P. 111549 - 111549

Published: Dec. 7, 2024

Language: Английский

Citations

3